X
XBI
OtherSPDR(R) S&P(R) BIOTECH ETF
$137.68+3.89 (+2.91%)LIVE
Live · NYSE ARCA · May 13, Close
AI Insight
What's Moving XBI Today?
No stock-specific AI insight has been generated for XBI yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$8.7B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume8.5M
Avg Volume (10D)—
Shares Outstanding63.2M
XBI News
20 articles- Moderna Shares Have Rallied. Why the Stock Could Climb Another 30%.Yahoo Finance·May 11, 2026
- Why This Biotech ETF — The IBD Stock Of The Day — Just Reentered Its Buy ZoneYahoo Finance·May 4, 2026
- Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's WhyYahoo Finance·May 1, 2026
- Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% From Here.Yahoo Finance·Apr 28, 2026
- LABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout247 Wall St·Apr 27, 2026
- Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here’s How to Position Now247 Wall St·Apr 23, 2026
- Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?Yahoo Finance·Apr 22, 2026
- Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.Wall Street Journal·Apr 13, 2026
- Leaderboard Trimmed, But Cloudflare, Caterpillar Among 5 Stocks To WatchYahoo Finance·Apr 6, 2026
- This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.247 Wall St·Apr 3, 2026
- MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance247 Wall St·Mar 29, 2026
- Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?Yahoo Finance·Mar 25, 2026
- This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight ResetMotley Fool·Mar 22, 2026
- This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue GrowthMotley Fool·Mar 22, 2026
- This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in CashMotley Fool·Mar 22, 2026
- DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC FilingMotley Fool·Mar 21, 2026
- How Is Bio-Techne's Stock Performance Compared to Other Biotechnology StocksBarchart·Mar 20, 2026
- The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOMYahoo Finance·Mar 17, 2026
- BioNTech Stock Is a Bargain. Why Its Recent Selloff Is a Buying Opportunity.Yahoo Finance·Mar 16, 2026
- Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI WaveYahoo Finance·Mar 16, 2026
All 20 articles loaded
Price Data
Open$130.62
Previous Close$133.79
Day High$131.46
Day Low$128.99
52 Week High—
52 Week Low—
Fundamentals
Market Cap$8.7B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume8.5M
Avg Volume (10D)—
Shares Outstanding63.2M
About SPDR(R) S&P(R) BIOTECH ETF
SPDR(R) S&P(R) BIOTECH ETF (XBI) · Other
Listed January 31, 2006
Company Details
Security TypeETF
ExchangeNYSE ARCA
Currency—
Round Lot—
SIC—
CIK—
Composite FIGI—
Share Class FIGI—